journal article·2018-09-12

Magnetite Nanocontainers: Toward Injectable Highly Magnetic Materials for Targeted Drug Delivery

Elizaveta I. Anastasova, Artur Y. Prilepskii, Anna F. Fakhardo, Andrey S. Drozdov, Vladimir V. Vinogradov

ACS Applied Materials & Interfaces· Volume 10· Issue 36
Publisher page

Abstract

Nanocontainers based solely on magnetite NPs have been synthesized by indirect gelation of stable magnetite hydrosol at ambient temperature using the microemulsion-assisted sol-gel method. Containers synthesized have adjustable size and consist of ∼10 nm magnetite nanoparticles linked by Fe-O-Fe interparticle bonds. The material demonstrates high magnetization values up to 60 emu/g and low cytotoxicity against both HeLa and postnatal human fibroblast (up to 260 μg/mL). The systems developed are perspective as a drug depot, particularly for magnetically controlled thrombolysis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, St. Petersburg, 197101, Russian Federation

Funding

Russian Science Foundation

References (32)

Show source-provided references
1. 10.1038/nbt.333010.1038/nbt.3330 ↗
2. 10.1016/j.biomaterials.2014.10.05910.1016/j.biomaterials.2014.10.059 ↗
3. 10.1039/C4SC03549F10.1039/C4SC03549F ↗
4. 10.1088/1468-6996/16/2/02350110.1088/1468-6996/16/2/023501 ↗
5. 10.1039/C5RA16177K10.1039/C5RA16177K ↗
6. 10.1039/9781782626756-0049110.1039/9781782626756-00491 ↗
7. 10.1016/j.tibtech.2015.06.00610.1016/j.tibtech.2015.06.006 ↗
8. 10.1039/C4LC01246A10.1039/C4LC01246A ↗
9. 10.1002/adfm.20140389110.1002/adfm.201403891 ↗
10. 10.1016/j.bpj.2017.11.282610.1016/j.bpj.2017.11.2826 ↗
11. 10.1038/nm.373010.1038/nm.3730 ↗
12. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
13. 10.1002/adma.20040077110.1002/adma.200400771 ↗
14. 10.1016/j.arabjc.2010.09.02710.1016/j.arabjc.2010.09.027 ↗
15. 10.1080/0091403039025735910.1080/00914030390257359 ↗
16. 10.1016/j.jconrel.2015.12.01610.1016/j.jconrel.2015.12.016 ↗
17. 10.1039/C7SM01702B10.1039/C7SM01702B ↗
18. 10.1016/0001-8686(91)80027-H10.1016/0001-8686(91)80027-H ↗
19. 10.1016/j.jcis.2016.01.06110.1016/j.jcis.2016.01.061 ↗
20. 10.1002/anie.20080246910.1002/anie.200802469 ↗
21. 10.1006/jcis.1993.137410.1006/jcis.1993.1374 ↗
22. 10.1016/j.arabjc.2018.02.01110.1016/j.arabjc.2018.02.011 ↗
23. 10.1021/acs.chemmater.6b0019310.1021/acs.chemmater.6b00193 ↗
24. 10.1039/C6RA14711A10.1039/C6RA14711A ↗
25. 10.1016/0304-8853(94)90462-610.1016/0304-8853(94)90462-6 ↗
26. 10.1038/s41598-017-11673-410.1038/s41598-017-11673-4 ↗
27. 10.3109/17435390.2010.50298010.3109/17435390.2010.502980 ↗
28. 10.3109/17435390.2010.48920610.3109/17435390.2010.489206 ↗
29. 10.1016/j.freeradbiomed.2011.09.03010.1016/j.freeradbiomed.2011.09.030 ↗
30. 10.1039/C8TB00072G10.1039/C8TB00072G ↗
31. 10.2214/ajr.152.1.16710.2214/ajr.152.1.167 ↗
32. 10.1038/jcbfm.2009.19210.1038/jcbfm.2009.192 ↗